Surrey, United Kingdom

Paul Stroemer



Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2008-2010

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Paul Stroemer

Introduction

Paul Stroemer is a notable inventor based in Surrey, GB, recognized for his contributions to the field of cell biology. With a total of three patents to his name, Stroemer has made significant advancements that have implications in medical research and biotechnology.

Latest Patents

Stroemer's latest patents focus on innovative cell lines. One of his inventions relates to cells obtainable from cell lines having the ECACC Accession Nos 04091601, 04110301, and 04092302. Another patent addresses genomic instability in T-antigen expressing cells, proposing a method to overcome this issue by modifying the gene that expresses T-antigen to lack Bub1 binding. This modification allows for the production of stable cell lines through the incorporation of the modified T-antigen gene, preferably alongside the catalytic sub-unit of the telomerase construct.

Career Highlights

Stroemer is currently associated with Reneuron, Inc., where he continues to push the boundaries of scientific research. His work has been instrumental in developing new methodologies that enhance the stability and functionality of cell lines used in various applications.

Collaborations

Throughout his career, Stroemer has collaborated with esteemed colleagues such as John Sinden and Kenneth Pollock. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Paul Stroemer's contributions to the field of cell biology through his patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in biotechnology and medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…